Technology | Tumor Tracking Systems | December 02, 2015

Philips Launches IntelliSpace Portal 8.0

Latest edition features full oncology suite, cardiac MR quantification and analysis 

Philips, Intellispace Portal 8.0, oncology suite, EASL, RSNA 2015

December 2, 2015 — Philips announced IntelliSpace Portal 8.0, the latest edition of its advanced data sharing, analytics and visualization platform that helps radiologists detect, diagnose and follow up on treatment of diseases. Introduced at the 2015 Radiological Society of North America Annual Meeting (RSNA) in Chicago, IntelliSpace Portal 8.0 helps address the changing demands in radiology that result from an increasing prevalence of cancer and its economic toll. It delivers new applications – like fast 3-D quantitative renderings of tumors – in a fully integrated oncology suite to improve diagnostic confidence and patient care.

The portal helps clinicians visualize, diagnose, measure disease states and communicate across modalities, with one efficient, automated and guided workflow. The latest release now features more than 68 clinical applications for seven modalities including computed tomography (CT), magnetic resonance (MR), ultrasound, mammography and interventional X-ray (iXR).

A key but challenging clinical need for today’s radiologists is determining how tumors are reacting to new local image-guided treatment approaches, such as tumor ablation and chemoembolization. Currently, this is done by evaluating one- or two-dimensional MRI images taken after the procedure, which give only limited insight and no quantified information. With the growing interest in finding new 3-D quantification options, IntelliSpace Portal 8.0 now includes, as an option for qualified researchers, qEASL, a quantitative technology which can be used in conjunction with its Multi-Modality Tumor Tracking (MMTT) application. With this technology, researchers can make a specialized analysis of 3-D imaging scans (e.g. CT and MRI) with the aim to enhance measurement of living and dying tumor tissue by giving them a visual indication of how cells respond to therapy. qEASL has been developed in close collaboration with leading clinical scientists at Yale School of Medicine and aims to improve the current standard for cancer treatment follow-ups as defined by the European Association for the Study of the Liver (EASL).

“Image-guided local tumor therapies are very difficult to evaluate for effectiveness, and traditional methods lack reproducibility and involve some level of guesswork,” said Jean-Francois (Jeff) Geschwind, M.D., chairman, Department of Radiology and Biomedical Imaging at Yale School of Medicine. “Redefining and standardizing how we assess this kind of treatment is revolutionary for radiology and the kind of care we can deliver for patients.”

IntelliSpace Portal 8.0 features enhanced capabilities and enriched clinical decision support:

  • With the increasing interest in pulmonary care, IntelliSpace Portal 8.0 now includes the new CT Lung Nodule Assessment (LNA) application designed for a more efficient and longitudinal workflow, which features a risk assessment tool for clinical decision support;
  • Through the Lung Nodule CAD, radiologists also have access to the computer-aided detection system for chest multi-slice CT exams;
  • A complete pulmonary solution, IntelliSpace Portal 8.0 also includes applications to aid clinicians in measuring and tracking chronic obstructive pulmonary disease (COPD), detecting pulmonary emboli and performing calcium scoring;
  • Embedded in the entire cardiac workflow, the MR Cardiac Quantitative Mapping enables fast quantification and analysis workflow for T1, T2 and T2 generated maps to enhance the diagnostic view in cardiomyopathies (disease of the heart muscle);
  • Enhanced capabilities in the Multi-Modality Viewer allow for the review, editing and analysis of Philips iXR and general radiology datasets. MR Smart Display Protocols deliver the best-fitting display protocols for each individual patient based on the radiologist’s preferred initial viewing layouts; and
  • The advanced capabilities of IntelliSpace Portal 8.0 will also assist in complying with Meaningful Use legislation in the United States by empowering radiologists to update electronic medical records (EMRs) easily and share patient information with various organizations such as public health agencies and specialized registries. With enhanced reporting features, radiologists can augment clinical reports with exportable graphs and tables, which can be collated into a single patient report and stored directly on the picture archiving and communication system (PACS) or radiology information system (RIS).

Philips hosted a special event during RSNA highlighting the MMTT qEASL concept, featuring Philips physician partners from Yale University, Charité Berlin and MD Anderson discussing volumetric measurements as a concept for response assessment in cancer treatment.

For more information: www.philips.com

Related Content

Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
First GammaTile Therapy Case Completed in Arizona
News | Radiation Therapy | August 19, 2019
HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a...
Lunit Receives Korea MFDS Approval for Lunit Insight MMG
News | Artificial Intelligence | August 19, 2019
Lunit has announced Korea Ministry of Food and Drug Safety (MFDS) approval of its artificial intelligence (AI) solution...
Drug Accelerates Blood System's Recovery After Radiation, Chemotherapy

Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications

News | Radiation Therapy | August 16, 2019
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem...
Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality

Catalyst PT image courtesy of C-RAD

News | Patient Positioning Radiation Therapy | August 15, 2019
Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton...
First Patient Enrolled in World's Largest Brain Cancer Clinical Trial
News | Radiation Therapy | August 15, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive...
Efficacy of Isoray's Cesium Blu Showcased in Recent Studies
News | Brachytherapy Systems | August 14, 2019
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica
Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...